| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |